Washington D.C. – A groundbreaking study presented at the American College of Cardiology’s Annual Scientific Session (ACC.25) is poised to revolutionize routine women’s health screenings, revealing that mammograms, traditionally used to detect breast cancer, can offer far more profound insights into a woman’s overall health. With the sophisticated assistance of artificial intelligence (AI) models, these essential imaging tools are demonstrating an unprecedented capability to assess cardiovascular health by quantifying calcium buildup in breast arteries – a critical, yet often overlooked, indicator of heart disease risk.
This innovative research underscores a potential paradigm shift, transforming a single screening test into a powerful dual-purpose diagnostic. The findings highlight how AI can unlock a wealth of previously untapped information from existing medical images, offering a proactive approach to identifying cardiovascular disease, particularly in women where it remains stubbornly underdiagnosed.
A Dual-Purpose Screening Revolution
The core revelation of the study centers on breast arterial calcification (BAC). While these calcifications, appearing as bright pixels on mammogram X-rays, have long been visible to radiologists, their significance for cardiovascular health has largely remained unquantified and unreported in routine practice. The new AI-powered technique changes this, providing an automated method to analyze BAC and translate it into a tangible cardiovascular risk score.
"We see an opportunity for women to get screened for cancer and also additionally get a cardiovascular screen from their mammograms," stated Dr. Theo Dapamede, a postdoctoral fellow at Emory University in Atlanta and the study’s lead author. His remarks encapsulate the profound potential of this research: to leverage an already widely adopted screening method for a broader, more holistic health assessment. "Our study showed that breast arterial calcification is a good predictor for cardiovascular disease, especially in patients younger than age 60. If we are able to screen and identify these patients early, we can refer them to a cardiologist for further risk assessment."
The Unseen Threat: Cardiovascular Disease in Women
The U.S. Centers for Disease Control and Prevention (CDC) recommends that middle-aged and older women undergo a mammogram every one or two years for breast cancer screening. Annually, approximately 40 million mammograms are performed across the United States, generating a vast repository of images. While radiologists routinely observe breast artery calcifications on these images, the absence of a standardized, automated quantification method has meant that this vital information rarely reaches women or their clinicians in a clinically actionable format.
This oversight is particularly critical given the landscape of women’s health. Heart disease remains the leading cause of death in the United States, claiming more lives than all cancers combined. Despite this sobering statistic, cardiovascular disease is notoriously underdiagnosed in women, often due to atypical symptoms, misattribution of symptoms, and a general lagging awareness among both the public and, at times, medical professionals regarding its prevalence and specific manifestations in female patients. The ability to "opportunistically screen" for cardiovascular risk during a routine cancer screening could therefore represent a monumental leap forward in addressing this critical public health challenge.
A buildup of calcium in blood vessels is a well-established sign of cardiovascular damage, indicative of early-stage heart disease or the natural process of aging. Previous epidemiological studies have consistently demonstrated a clear link, showing that women with detectable calcium buildup in their arteries face a significantly elevated risk – specifically, a 51% higher risk – of experiencing serious cardiovascular events such as heart disease and stroke. The challenge has always been to systematically identify and act upon this information.
Bridging the Gap: AI’s Role in Early Detection
The breakthrough lies in the sophisticated application of artificial intelligence. Researchers meticulously trained a deep-learning AI model to interpret mammogram images with unprecedented precision. The model’s primary task was to "segment" calcified vessels, which appear as distinct bright pixels on X-rays, and then accurately calculate the extent of this calcification. This raw data was then cross-referenced with comprehensive electronic health record data to predict the future risk of cardiovascular events.
What sets this AI model apart from previous attempts to analyze breast artery calcifications is its advanced "segmentation approach." Instead of merely detecting the presence of calcification, this model precisely delineates the boundaries and volume of the calcified areas, offering a more nuanced and quantitative assessment. This precision allows for a more accurate and robust estimation of risk.
The robustness of the model is further bolstered by the sheer scale and quality of its training and testing dataset. Researchers utilized images and health records from over 56,000 patients who underwent mammograms at Emory Healthcare between 2013 and 2020. Crucially, this dataset included at least five years of follow-up electronic health records data for each patient, providing invaluable longitudinal information to correlate BAC levels with actual cardiovascular outcomes. Such a large and comprehensive dataset minimizes bias and enhances the generalizability of the model’s findings, making its predictions more reliable.
Dr. Dapamede emphasized the broader implications of this technological advancement: "Advances in deep learning and AI have made it much more feasible to extract and use more information from images to inform opportunistic screening." This concept of "opportunistic screening" is central to the study’s potential impact – transforming a routine check-up into a multi-faceted health assessment without requiring additional patient visits or specialized equipment, thereby increasing accessibility and reducing healthcare burden.
Unpacking the Study’s Landmark Findings
The overall findings of the study were compelling and highly encouraging. The newly developed AI model demonstrated remarkable proficiency in characterizing patients’ cardiovascular risk, effectively categorizing it as low, moderate, or severe based solely on the analysis of mammogram images. This ability to stratify risk is fundamental for clinical decision-making, allowing healthcare providers to tailor interventions to individual patient needs.
A key revelation was the strong correlation between the level of breast arterial calcification and the subsequent rate of serious cardiovascular events. After meticulously calculating the risk of dying from any cause or suffering an acute heart attack, stroke, or heart failure at both two-year and five-year intervals, the model consistently showed that the incidence of these critical cardiovascular events escalated in direct proportion to the level of BAC.
This correlation was particularly pronounced and clinically significant in two of the three age categories assessed: women younger than age 60 and those between age 60-80. While the correlation was less evident in women over age 80, this finding itself is crucial. It underscores the tool’s particular utility for providing an early warning of heart disease risk in younger women, who stand to benefit most from early interventions. Identifying risk factors in women under 60 allows for proactive lifestyle modifications, targeted medication, and closer monitoring, potentially preventing the onset or progression of debilitating cardiovascular disease.
The quantitative results further solidified these observations. Women with the highest level of breast arterial calcification (defined as above 40 mm²) exhibited a significantly lower five-year rate of event-free survival compared to those with the lowest level (below 10 mm²). For instance, only 86.4% of women in the highest BAC category survived for five years without a major cardiovascular event, in stark contrast to 95.3% of those with the lowest level of calcification. This translates into a sobering statistic: patients with severe breast arterial calcification face approximately 2.8 times the risk of death within five years compared to those with little to no breast arterial calcification. These figures provide a clear, quantifiable measure of the risk associated with elevated BAC, empowering clinicians and patients with actionable data.
Paving the Way: Collaboration, Validation, and Future Horizons
The development of this innovative AI model was a collaborative effort between Emory Healthcare and the Mayo Clinic, combining the expertise of two leading medical institutions. While the preliminary results are exceptionally promising, the model is not yet commercially available for widespread clinical use. The path forward involves a rigorous process of external validation to confirm its performance across diverse patient populations and healthcare settings.
Following successful external validation, the tool will then need to gain approval from the U.S. Food and Drug Administration (FDA). This regulatory step is critical to ensure its safety, efficacy, and reliability before it can be integrated into routine medical practice. Should it clear these hurdles, researchers anticipate that the tool could be made commercially available, allowing other health care systems to incorporate this advanced AI analysis into their routine mammogram processing and subsequent follow-up care pathways.
The implications extend beyond cardiovascular health. The researchers are already planning to explore how similar AI models could be adapted and used for assessing biomarkers for other medical conditions. For example, mammograms might hold hidden clues for conditions such as peripheral artery disease (PAD) and kidney disease, offering a tantalizing glimpse into a future where a single, common imaging test could provide a comprehensive "health snapshot," informing diagnosis and intervention for a multitude of conditions. This concept highlights the power of AI to extract nuanced information that the human eye, even that of a highly trained radiologist, might miss or find too time-consuming to quantify routinely.
A New Era for Proactive Women’s Health
This study marks a significant stride towards a more proactive and integrated approach to women’s health. By harnessing the power of AI, mammograms are poised to evolve from a cancer-specific screening tool into a broader health sentinel, capable of identifying early indicators of cardiovascular disease, the leading cause of mortality in women.
The potential benefits are multifaceted: earlier detection of heart disease, particularly in younger women who can benefit most from preventative measures; improved patient outcomes through timely referrals to cardiologists and tailored interventions; enhanced efficiency in healthcare delivery by maximizing the information gleaned from existing screenings; and a heightened awareness of cardiovascular risk among women and their clinicians.
As this technology progresses through validation and regulatory approval, it promises to usher in a new era where routine screenings offer deeper, more comprehensive insights into an individual’s overall health, empowering both patients and healthcare providers to make informed decisions that can profoundly impact longevity and quality of life. The future of women’s health, it seems, may be found in the subtle patterns detected by AI within the familiar images of a mammogram.
About the Author
